Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Syndromic Sensorineural Hearing Loss Treatment & Management

  • Author: Stephanie A Moody Antonio, MD; Chief Editor: Arlen D Meyers, MD, MBA  more...
 
Updated: Jan 13, 2016
 

Medical Care

See the list below:

  • Medical therapy: Treat any middle ear disease, including otitis media, with the appropriate medical therapy.
  • Amplification
    • The goal of amplification is to use any residual hearing to at least orient patients to surrounding environments. Hearing amplification can generally be implemented successfully during the first 6 weeks of life.
    • Available hearing amplification devices include conventional analog hearing aids, digital hearing aids, bone conduction hearing aids, and bone-anchored hearing aids. Other middle and inner ear implantable devices are undergoing clinical trials.
  • Assistive listening devices and personal systems
    • Personal devices, such as FM trainers, aid in reducing the signal-to-noise ratio in various listening situations with significant background noise, eg, classrooms.
    • Telephone devices can include such items as volume controls and couplers for use with certain hearing aids, along with telecommunication devices for deaf persons who are unable to use standard telephones.
    • Closed captioning allows television use for individuals who are severely hearing impaired.
    • Signaling devices substitute visual signals for auditory signals. They can detect environmental sounds, such as doorbells, telephones, alarm clocks, fire alarms, or crying babies.
Next

Surgical Care

Surgical management of external and middle ear deformities can be recommended for bilateral hearing loss and some unilateral cases.

  • Cochlear implantation
    • Cochlear implants are electronic devices designed to convert mechanical sound energy into electric signals that can be delivered to the cochlear nerve.
    • Consider cochlear implantation for patients who do not significantly benefit from conventional hearing amplification.
    • To preoperatively ensure the presence of an intact cochlear nerve, consider MRI. CT scan of the temporal bones is routinely performed to identify cochlear abnormalities.
    • Children younger than 5 years who have restored auditory input via cochlear implantation achieve substantially better language skills. Cochlear implantation may be performed at age 1 year.
Previous
Next

Consultations

See the list below:

  • Geneticist
    • Geneticists may offer assistance in establishing the etiology of SNHL.
    • Geneticists also provide genetic counseling to address a family's questions about the etiology of the patient's hearing loss and the risk of recurrence for future children.
  • Audiologist
    • Audiologists assist in selecting the most appropriate hearing aid for the patient. Selection of the appropriate aid is critical and is usually the responsibility of the audiologist.
    • Systematic monitoring is necessary to ensure proper function of the device while monitoring speech and language development.
  • Speech and language pathologist
    • Patients' linguistic and communicative skills must be analyzed while understanding that language capability, and not the hearing level, is the final indication of a successful habilitative program.
    • Normally, language should first be presented to children who are hearing impaired through all available inputs, including auditory, visual, and tactile stimuli.
  • Ophthalmologist: Consider consultation to assess visual acuity and to evaluate any possible ocular components of syndromic hearing loss.
Previous
 
 
Contributor Information and Disclosures
Author

Stephanie A Moody Antonio, MD Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School

Stephanie A Moody Antonio, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, Virginia Society of Otolaryngology-Head and Neck Surgery, American Neurotology Society, American Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Barry Strasnick, MD, FACS Chairman, Professor, Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School

Barry Strasnick, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Medical Association, American Tinnitus Association, Ear Foundation Alumni Society, Norfolk Academy of Medicine, North American Skull Base Society, Society of University Otolaryngologists-Head and Neck Surgeons, Vestibular Disorders Association, Virginia Society of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Ted L Tewfik, MD Professor of Otolaryngology-Head and Neck Surgery, Professor of Pediatric Surgery, McGill University Faculty of Medicine; Senior Staff, Montreal Children's Hospital, Montreal General Hospital, and Royal Victoria Hospital

Ted L Tewfik, MD is a member of the following medical societies: American Society of Pediatric Otolaryngology, Canadian Society of Otolaryngology-Head & Neck Surgery

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;SymbiaAllergySolutions<br/>Received income in an amount equal to or greater than $250 from: Symbia<br/>Received from Allergy Solutions, Inc for board membership; Received honoraria from RxRevu for chief medical editor; Received salary from Medvoy for founder and president; Received consulting fee from Corvectra for senior medical advisor; Received ownership interest from Cerescan for consulting; Received consulting fee from Essiahealth for advisor; Received consulting fee from Carespan for advisor; Received consulting fee from Covidien for consulting.

Additional Contributors

B Viswanatha, DO, MBBS, PhD, MS, FACS Professor of Otolaryngology (ENT), Sri Venkateshwara ENT Institute, Victoria Hospital, Bangalore Medical College and Research Institute, India

B Viswanatha, DO, MBBS, PhD, MS, FACS is a member of the following medical societies: Indian Medical Association, Indian Society of Otology, Association of Otolaryngologists of India

Disclosure: Nothing to disclose.

References
  1. Eisen MD, Ryugo DK. Hearing molecules: contributions from genetic deafness. Cell Mol Life Sci. 2007 Mar. 64(5):566-80. [Medline].

  2. Mehra S, Eavey RD, Keamy DG Jr. The epidemiology of hearing impairment in the United States: newborns, children, and adolescents. Otolaryngol Head Neck Surg. 2009 Apr. 140(4):461-72. [Medline].

  3. Morzaria S, Westerberg BD, Kozak FK. Systematic review of the etiology of bilateral sensorineural hearing loss in children. Int J Pediatr Otorhinolaryngol. 2004 Sep. 68(9):1193-8. [Medline].

  4. Saunders JE, Vaz S, Greinwald JH, Lai J, Morin L, Mojica K. Prevalence and etiology of hearing loss in rural Nicaraguan children. Laryngoscope. 2007 Mar. 117(3):387-98. [Medline].

  5. Huang BY, Zdanski C, Castillo M. Pediatric sensorineural hearing loss, part 2: syndromic and acquired causes. AJNR Am J Neuroradiol. 2012 Mar. 33(3):399-406. [Medline].

  6. Information on Hearing Loss - Ten Syndromes Most Commonly Associated With Hearing Impairment. boystownhospital.org. Available at http://boystownhospital.org/Hearing/info/genetics/syndromes/ten.asp. Accessed: April 14, 2009.

  7. Song J, Feng Y, Acke FR, Coucke P, Vleminckx K, Dhooge IJ. Hearing loss in Waardenburg syndrome: a systematic review. Clin Genet. 2015 Jun 22. [Medline].

  8. Usher Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=ushersyndrome. Accessed: April 14, 2009.

  9. Pendred Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=pendredsyndrome. Accessed: April 14, 2009.

  10. Jervell and Lange-Nielson Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=jervellandlangenielsensyndrome. Accessed: April 14, 2009.

  11. Cockayne Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=cockaynesyndrome.

  12. Alstrom Disease. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=alstromsyndrome. Accessed: April 14, 2009.

  13. Nadol JB Jr, Marshall JD, Bronson RT. Histopathology of the human inner ear in Alstrom's syndrome. Audiol Neurootol. 2015. 20 (4):267-72. [Medline].

  14. Merchant SN, Burgess BJ, Adams JC, Kashtan CE, Gregory MC, Santi PA. Temporal bone histopathology in alport syndrome. Laryngoscope. 2004 Sep. 114(9):1609-18. [Medline].

  15. Norrie Disease. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=norriedisease. Accessed: April 14, 2009.

  16. FDA approves first implantable hearing device for adults with a certain kind of hearing loss. US Food and Drug Administration. March 20, 2014. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm389860.htm.

  17. Alport Syndrome. Genetics Home Reference. Available at http://ghr.nlm.nih.gov/condition=alportsyndrome. Accessed: April 14, 2009.

  18. Alstrom CH. Retinal degeneration combined with obesity, diabetes mellitus and neurogenous disease. Acta Psychiatrica Scandinavica. 1959. 34:1-35.

  19. Cockayne E. Dwarfism with retinal atrophy and deafness. Arch Dis Child. 1936. 2:1.

  20. Jervell A, Lange-Nielsen J. Congenital deaf-mutism functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957. 54:9-68.

  21. National Newborn Screening Status ReportUpdated 03/11/09. Available at http://genes-r-us.uthscsa.edu/nbsdisorders.pdf.

  22. Ouyang SM, Yan D, Yuan HJ, et al. The genetic basis of non-syndromic hearing loss among Chinese. Journal Human Genetics. 2009. 54(3):131-40.

  23. Refsum S. Heredopathia actica polyneuritis formis. Acta Psychiatrica Scandinavica. 1946. 38:301-303.

  24. Strome M. Down's syndrome: a modern otorhinolaryngological perspective. Laryngology. 1959. 69:54-89.

  25. Usher CH. On the inheritance of retinitis pigmentosa, with notes of a case. London Ophthalmol Hosp Nep. 1914. 19:130-136.

  26. Waardenburg PJ. A new syndrome combining developmental anomalies of the eyelids, eyebrows, and nose root with pigmentary defects of the iris and head hair and with congenital deafness. Am J Hum Gen. 1951. 3:195-253.

Previous
Next
 
Inner ear.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.